Chartier-Harlin MC - Search Results

1

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

Lambert JC, Mann D, Goumidi L, Harris J, Amouyel P, Iwatsubo T, Lendon C, Chartier-Harlin MC. Lambert JC, et al. Lancet. 2001 Feb 24;357(9256):608-9. doi: 10.1016/S0140-6736(00)04063-0. Lancet. 2001. PMID: 11558492

2

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.

Zhang Y, Hayes A, Pritchard A, Thaker U, Haque MS, Lemmon H, Harris J, Cumming A, Lambert JC, Chartier-Harlin MC, St Clair D, Iwatsubo T, Mann DM, Lendon CL. Zhang Y, et al. Neurosci Lett. 2004 May 20;362(2):99-102. doi: 10.1016/j.neulet.2004.03.008. Neurosci Lett. 2004. PMID: 15193763

3

Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.

Pritchard A, Harris J, Pritchard CW, St Clair D, Lemmon H, Lambert JC, Chartier-Harlin MC, Hayes A, Thaker U, Iwatsubo T, Mann DM, Lendon C. Pritchard A, et al. Neurosci Lett. 2005 Jul 15;382(3):221-6. doi: 10.1016/j.neulet.2005.03.016. Epub 2005 Apr 21. Neurosci Lett. 2005. PMID: 15925094

4

Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group.

Pérez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier-Harlin MC. Pérez-Tur J, et al. Lancet. 1996 Jun 1;347(9014):1560-1. Lancet. 1996. PMID: 8684137 No abstract available.

5

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1997 Nov;6(12):2151-4. doi: 10.1093/hmg/6.12.2151. Hum Mol Genet. 1997. PMID: 9328480

6

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Mar;7(3):533-40. doi: 10.1093/hmg/7.3.533. Hum Mol Genet. 1998. PMID: 9467014

7

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Lambert JC, Wavrant-De Vrièze F, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Lancet. 1998 Jun 13;351(9118):1787-8. doi: 10.1016/s0140-6736(05)78749-3. Lancet. 1998. PMID: 9635959 No abstract available.

8

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Sep;7(9):1511-6. doi: 10.1093/hmg/7.9.1511. Hum Mol Genet. 1998. PMID: 9700208

9

The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease.

Lambert JC, Goumidi L, Vrièze FW, Frigard B, Harris JM, Cummings A, Coates J, Pasquier F, Cottel D, Gaillac M, St Clair D, Mann DM, Hardy J, Lendon CL, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 2000 Sep 22;9(15):2275-80. doi: 10.1093/oxfordjournals.hmg.a018918. Hum Mol Genet. 2000. PMID: 11001930

10

A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains.

Lambert JC, Mann D, Goumidi L, Harris J, Pasquier F, Frigard B, Cottel D, Lendon C, Iwatsubo T, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Neurosci Lett. 2000 Oct 20;293(1):29-32. doi: 10.1016/s0304-3940(00)01477-4. Neurosci Lett. 2000. PMID: 11065130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters